Seascape Capital Management Sells 713 Shares of Church & Dwight Co., Inc. (NYSE:CHD)

Seascape Capital Management trimmed its stake in shares of Church & Dwight Co., Inc. (NYSE:CHD) by 1.9% during the 1st quarter, Holdings Channel.com reports. The fund owned 36,834 shares of the company’s stock after selling 713 shares during the quarter. Church & Dwight accounts for approximately 1.4% of Seascape Capital Management’s portfolio, making the stock its 26th largest position. Seascape Capital Management’s holdings in Church & Dwight were worth $4,055,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of the stock. IAG Wealth Partners LLC lifted its stake in shares of Church & Dwight by 92.9% in the 1st quarter. IAG Wealth Partners LLC now owns 270 shares of the company’s stock valued at $30,000 after purchasing an additional 130 shares during the period. Bernard Wealth Management Corp. purchased a new position in shares of Church & Dwight in the 4th quarter valued at approximately $40,000. Wayfinding Financial LLC purchased a new position in shares of Church & Dwight in the 1st quarter valued at approximately $40,000. Versant Capital Management Inc lifted its stake in shares of Church & Dwight by 42.1% in the 1st quarter. Versant Capital Management Inc now owns 378 shares of the company’s stock valued at $42,000 after purchasing an additional 112 shares during the period. Finally, Banque Transatlantique SA purchased a new position in Church & Dwight during the fourth quarter valued at $46,000. 86.60% of the stock is currently owned by institutional investors.

Church & Dwight Stock Performance

Shares of CHD stock opened at $98.41 on Friday. The firm has a market capitalization of $24.24 billion, a price-to-earnings ratio of 42.24, a price-to-earnings-growth ratio of 3.95 and a beta of 0.51. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.95 and a quick ratio of 1.43. The business has a fifty day moving average of $96.46 and a 200 day moving average of $102.81. Church & Dwight Co., Inc. has a 1 year low of $90.99 and a 1 year high of $116.46.

Church & Dwight (NYSE:CHD) last issued its quarterly earnings data on Thursday, May 1st. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.89 by $0.02. Church & Dwight had a return on equity of 19.28% and a net margin of 9.52%. The business had revenue of $1.47 billion during the quarter, compared to analysts’ expectations of $1.52 billion. During the same quarter in the previous year, the firm posted $0.96 EPS. The company’s revenue for the quarter was down 2.4% on a year-over-year basis. As a group, research analysts expect that Church & Dwight Co., Inc. will post 3.7 earnings per share for the current year.

Church & Dwight Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, June 2nd. Shareholders of record on Thursday, May 15th were paid a dividend of $0.295 per share. The ex-dividend date of this dividend was Thursday, May 15th. This represents a $1.18 annualized dividend and a yield of 1.20%. Church & Dwight’s dividend payout ratio (DPR) is currently 50.64%.

Insider Activity at Church & Dwight

In related news, CEO Richard A. Dierker acquired 7,950 shares of the stock in a transaction on Tuesday, May 13th. The shares were bought at an average price of $94.66 per share, with a total value of $752,547.00. Following the completion of the purchase, the chief executive officer owned 16,358 shares of the company’s stock, valued at approximately $1,548,448.28. This represents a 94.55% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Carlen Hooker sold 6,380 shares of the company’s stock in a transaction that occurred on Monday, June 16th. The shares were sold at an average price of $98.30, for a total value of $627,154.00. Following the completion of the transaction, the executive vice president owned 262 shares in the company, valued at $25,754.60. This represents a 96.06% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 50,575 shares of company stock worth $4,910,586 in the last quarter. Corporate insiders own 2.00% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have issued reports on CHD shares. Wall Street Zen upgraded Church & Dwight from a “sell” rating to a “hold” rating in a research note on Saturday, June 21st. UBS Group cut their price objective on Church & Dwight from $110.00 to $102.00 and set a “neutral” rating for the company in a report on Friday, May 2nd. Bank of America raised Church & Dwight from a “neutral” rating to a “buy” rating and lifted their price objective for the stock from $112.00 to $125.00 in a report on Tuesday, April 15th. Evercore ISI cut their price target on Church & Dwight from $106.00 to $102.00 and set an “in-line” rating for the company in a report on Friday, May 2nd. Finally, JPMorgan Chase & Co. cut their price target on Church & Dwight from $106.00 to $98.00 and set an “underweight” rating for the company in a report on Friday, April 11th. Two equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and seven have assigned a buy rating to the company’s stock. According to MarketBeat.com, Church & Dwight currently has an average rating of “Hold” and a consensus target price of $108.29.

About Church & Dwight

Church & Dwight Co, Inc engages in the development, manufacture, and marketing of household, personal care, and specialty products. It operates through the following segments: Consumer Domestic, Consumer International, Specialty Products Division (SPD), and Corporate. The Consumer Domestic segment offers household products, such as laundry detergents, fabric softener sheets, cat litter, household cleaning products, and personal care products including antiperspirants, oral care products, depilatories, reproductive health products, oral analgesics, nasal saline moisturizers, and dietary supplements.